Literature DB >> 10909873

Sequence-specific 1H, 15N, and 13C assignment of the N-terminal domain of the human oncoprotein MDM2 that binds to p53.

R Stoll, C Renner, P Mühlhahn, S Hansen, R Schumacher, F Hesse, B Kaluza, R A Engh, W Voelter, T A Holak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10909873     DOI： 10.1023/a:1008365622798

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN： 0925-2738            Impact factor:   2.835


× No keyword cloud information.
  9 in total

1.  Mapping of the p53 and mdm-2 interaction domains.

Authors:  J Chen; V Marechal; A J Levine
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

Review 2.  MDM2 function.

Authors:  G Lozano; R Montes de Oca Luna
Journal:  Biochim Biophys Acta       Date:  1998-04-17

3.  p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.

Authors:  C A Midgley; D P Lane
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

4.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

5.  Refolding and association of oligomeric proteins.

Authors:  R Jaenicke; R Rudolph
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

6.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

7.  Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.

Authors:  W Kalus; M Zweckstetter; C Renner; Y Sanchez; J Georgescu; M Grol; D Demuth; R Schumacher; C Dony; K Lang; T A Holak
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.

Authors:  C Wasylyk; R Salvi; M Argentini; C Dureuil; I Delumeau; J Abecassis; L Debussche; B Wasylyk
Journal:  Oncogene       Date:  1999-03-18       Impact factor: 9.867

9.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.

Authors:  J D Oliner; J A Pietenpol; S Thiagalingam; J Gyuris; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962
  9 in total
  2 in total

1.  Identification of Secondary Binding Sites on Protein Surfaces for Rational Elaboration of Synthetic Protein Mimics.

Authors:  Justin M Torner; Yuwei Yang; David Rooklin; Yingkai Zhang; Paramjit S Arora
Journal:  ACS Chem Biol       Date:  2021-07-06       Impact factor: 4.634

2.  Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.

Authors:  Peter M Fischer
Journal:  Int J Pept Res Ther       Date:  2006-03-15       Impact factor: 1.931
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.